Background Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational …

Importance The risk of venous thromboembolism (VTE) in ambulatory COVID-19 is controversial.
In addition, the association of vaccination with COVID-19–related VTE and relevant …

Background Hydroxychloroquine has recently received Emergency Use Authorization by the
FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia. …

Background Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid
arthritis, has received much negative publicity for adverse events associated with its …

In this international study, we examined the incidence of hip fractures, postfracture treatment,
and all‐cause mortality following hip fractures, based on demographics, geography, and …

Background Before the COVID-19 pandemic, Sexually transmitted infections (STIs) were
increasing in Europe, and Spain and Catalonia were not an exception. Catalonia has been one …

The natural history of coronavirus disease 2019 (COVID-19) has yet to be fully described.
Here, we use patient-level data from the Information System for Research in Primary Care (…

Objective To investigate the use of repurposed and adjuvant drugs in patients admitted to
hospital with covid-19 across three continents. Design Multinational network cohort study. …

OBJECTIVES To characterize the demographics, comorbidities, symptoms, in-hospital
treatments, and health outcomes among children and adolescents diagnosed or hospitalized with …

Comorbid conditions appear to be common among individuals hospitalised with coronavirus
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …